| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alaunos Therapeutics, Inc. (TCRT) has 5 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. TCRT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 43.9K | $113.2K | - | |
| Dir | 32.3K | $83.4K | - | |
| CEO | 13.7K | $35.3K | - | |
| VP | 10.8K | $27.8K | - | |
| Dir | 9.6K | $24.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2020 | Lafond Kevin G | SVP, Treasurer &CAO | Sell | 21,570 | $4.55 | $98,143.50 | -25.2% | |
| Dec 30, 2019 | Cooper Laurence James Neil | Chief Executive Officer | Sale+OE | 110,694 | $4.88 | $540,186.72 | -6.0% | |
| Nov 26, 2019 | Lafond Kevin G | SVP, Treasurer &CAO | Sale+OE | 11,667 | $5.25 | $61,251.75 | -12.0% | |
| Nov 8, 2017 | Mauney David M Md | EVP And Chief Business Officer | Buy | 4,270 | $4.68 | $19,983.60 | +7.9% | |
| Nov 8, 2017 | Cooper Laurence James Neil | Chief Executive Officer | Buy | 6,440 | $4.68 | $30,139.20 | +0.6% | |
| Nov 19, 2015 | Belbel Caesar J | COO, CLO, And Secretary | Sale+OE | 153,333 | $12.84 | $1,968,795.72 | -72.1% | |
| Jun 9, 2015 | Lebel Francois | Executive Vice President R&D | Sale+OE | 50,000 | $10.12 | $506,000.00 | -100% | |
| Jun 4, 2015 | Brennan Murray | Director | Sell | 40,000 | $9.70 | $387,807.71 | -56.5% | |
| Jun 3, 2015 | Lafond Kevin G | Vice Pres., Treasurer, &CAO | Sale+OE | 57,500 | $9.65 | $555,083.40 | -100% | |
| Feb 9, 2015 | Kirk Randal J | Director, 10% Owner | Buy | 1,440,000 | $8.75 | $12,600,000.00 | +8.8% |